Literature DB >> 10197390

Pneumocystosis versus pulmonary Pneumocystis carinii colonization in HIV-negative and HIV-positive patients.

G Nevez, C Raccurt, V Jounieaux, E Dei-Cas, E Mazars.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10197390     DOI： 10.1097/00002030-199903110-00020

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  22 in total

1.  Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.

Authors:  Heather M Kling; Timothy W Shipley; Siobhan Guyach; Rebecca Tarantelli; Alison Morris; Karen A Norris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

2.  Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia.

Authors:  Hans Henrik Larsen; Henry Masur; Joseph A Kovacs; Vee J Gill; Victoria A Silcott; Palaniandy Kogulan; Janine Maenza; Margo Smith; Daniel R Lucey; Steven H Fischer
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia.

Authors:  R F Miller; H E Ambrose; A E Wakefield
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Population structure of rat-derived Pneumocystis carinii in Danish wild rats.

Authors:  R J Palmer; O P Settnes; J Lodal; A E Wakefield
Journal:  Appl Environ Microbiol       Date:  2000-11       Impact factor: 4.792

5.  Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.

Authors:  Céline Damiani; Solène Le Gal; Cécilia Da Costa; Michèle Virmaux; Gilles Nevez; Anne Totet
Journal:  J Clin Microbiol       Date:  2013-07-31       Impact factor: 5.948

Review 6.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

7.  Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study.

Authors:  N A Maskell; D J Waine; A Lindley; J C T Pepperell; A E Wakefield; R F Miller; R J O Davies
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

8.  Genotypic variation in Pneumocystis jirovecii isolates in Britain.

Authors:  R F Miller; A R Lindley; A Copas; H E Ambrose; R J O Davies; A E Wakefield
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

9.  Characterization of PCEng2, a {beta}-1,3-endoglucanase homolog in Pneumocystis carinii with activity in cell wall regulation.

Authors:  Leah R Villegas; Theodore J Kottom; Andrew H Limper
Journal:  Am J Respir Cell Mol Biol       Date:  2009-09-25       Impact factor: 6.914

10.  Immunocompetent hosts as a reservoir of pneumocystis organisms: histological and rt-PCR data demonstrate active replication.

Authors:  M Chabé; E Dei-Cas; C Creusy; L Fleurisse; N Respaldiza; D Camus; I Durand-Joly
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-08       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.